EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sustainable Nanomedicine: Enhancement of Asplatin’s Cytotoxicity In Vitro and In Vivo Using Green-Synthesized Zinc Oxide Nanoparticles Formed via Microwave-Assisted and Gambogic Acid-Mediated Processes

Hatem A F M Hassan iD, Nada K Sedky iD, Mohamed S Nafie iD, Noha Khalil Mahdy iD, Iten M Fawzy, Toka Waleed Fayed iD, Eduard Preis iD, Udo Bakowsky iD, Sherif Ashraf Fahmy iD

Molecules · 2024

DOI: 10.3390/molecules29225327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hatem A F M Hassan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medway School of Pharmacy, University of Kent, Chatham Maritime, Kent ME4 4TB, UK. Hauptthemen laut MEDLINE: Zinc Oxide, Microwaves, Xanthones, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt Foundation, Alexander von Humboldt Foundation, Germany, Open Access Publishing Fund of Philipps-Universität Marburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance encountered using conventional chemotherapy demands novel treatment approaches. Asplatin (Asp), a novel platinum (IV) prodrug designed to release cisplatin and aspirin in a reductive environment, has demonstrated high cytotoxicity at reduced drug resistance. Herein, we investigated the ability of green-synthesized nanocarriers to enhance Asp’s efficacy. Zinc oxide nanoparticles (ZnO-NPs) were synthesized using a green microwave-assisted method with the reducing and capping agent gambogic acid (GA). These nanoparticles were then loaded with Asp, yielding Asp@ZnO-NPs. Transmission electron microscopy was utilized to study the morphological features of ZnO-NPs. Cell viability studies conducted on MDA-MB-231 breast cancer cells demonstrated the ability of the Asp@ZnO-NPs treatment to significantly decrease Asp’s half-maximal inhibitory concentration (IC50) (5 ± 1 µg/mL). This was further demonstrated using flow cytometric analysis that revealed the capacity of Asp@ZnO-NPs treatment to significantly increase late apoptotic fractions. Furthermore, in vivo studies carried out using solid Ehrlich carcinoma-bearing mice showed significant tumor volume reduction with the Asp@ZnO-NPs treatment (156.3 ± 7.6 mm3), compared to Asp alone (202.3 ± 8.4 mm3) and untreated controls (342.6 ± 10.3 mm3). The histopathological analysis further demonstrated the increased necrosis in Asp@ZnO-NPs-treated group. This study revealed that Asp@ZnO-NPs, synthesized using an eco-friendly approach, significantly enhanced Asp’s anticancer activity, offering a sustainable solution for potent anticancer formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc OxideMicrowavesXanthonesAntineoplastic AgentsNanomedicineAnimalsHumansMiceCell Line, TumorGreen Chemistry TechnologyCell SurvivalNanoparticlesApoptosisFemaleOrganoplatinum Compounds

Stichwörter der Autor:innen

asplatincancer therapydrug deliverygreen synthesistriple-negative breast cancerzinc oxide nanoparticles

Substanzen

Zinc Oxidegambogic acidXanthonesAntineoplastic AgentsOrganoplatinum Compounds

Autor:innen und Institutionen

  • Medway School of Pharmacy, University of Kent, Chatham Maritime, Kent ME4 4TB, UK.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
  • Department of Biochemistry, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, R5 New Garden City, New Administrative Capital, Cairo 11835, Egypt.
  • Department of Chemistry, College of Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
  • Chemistry Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
  • School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, R5 New Garden City, New Administrative Capital, Cairo 11835, Egypt.

ORCID-Profile: Hatem A F M Hassan, Nada K Sedky, Mohamed S Nafie, Noha Khalil Mahdy, Toka Waleed Fayed, Eduard Preis, Udo Bakowsky, Sherif Ashraf Fahmy

Förderung

  • Alexander von Humboldt Foundation
  • Alexander von Humboldt Foundation, Germany
  • Open Access Publishing Fund of Philipps-Universität Marburg

Zitieren

APA

Hassan, H. A. F. M., Sedky, N. K., Nafie, M. S., Mahdy, N. K., Fawzy, I. M., Fayed, T. W., Preis, E., Bakowsky, U., & Fahmy, S. A. (2024). Sustainable Nanomedicine: Enhancement of Asplatin’s Cytotoxicity In Vitro and In Vivo Using Green-Synthesized Zinc Oxide Nanoparticles Formed via Microwave-Assisted and Gambogic Acid-Mediated Processes. Molecules. https://doi.org/10.3390/molecules29225327

Vancouver

Hassan HAFM, Sedky NK, Nafie MS, Mahdy NK, Fawzy IM, Fayed TW, et al. Sustainable Nanomedicine: Enhancement of Asplatin’s Cytotoxicity In Vitro and In Vivo Using Green-Synthesized Zinc Oxide Nanoparticles Formed via Microwave-Assisted and Gambogic Acid-Mediated Processes. Molecules. 2024. doi:10.3390/molecules29225327

BibTeX
@article{Hassan2024,
  author = {Hassan, Hatem A F M and Sedky, Nada K and Nafie, Mohamed S and Mahdy, Noha Khalil and Fawzy, Iten M and Fayed, Toka Waleed and Preis, Eduard and Bakowsky, Udo and Fahmy, Sherif Ashraf},
  title = {Sustainable Nanomedicine: Enhancement of Asplatin’s Cytotoxicity In Vitro and In Vivo Using Green-Synthesized Zinc Oxide Nanoparticles Formed via Microwave-Assisted and Gambogic Acid-Mediated Processes},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29225327}
}
Kostenlos starten →